Skip to main content

Table 3 Baseline imaging parameters of all patients, and patients discriminated with the presence of late gadolinium enhancement (LGE) and segmental wall motion abnormality (SWMA)

From: Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study

  All patients (n = 86) LGE negative (n = 25) LGE positive (n = 61) p-value SWMA negative (n = 30) SWMA positive (n = 56) p-value
Echocardiography        
LVEDD, mm 55 (48–61) 48 (44–54) 56 (50–63) < 0.001 48 (44–54) 59 (53–67) < 0.001
LVEF, % 50 (33–62) 62 (57–71) 42 (25–56) < 0.001 63 (60–70) 38 (23–52) < 0.001
CMR        
LVEDV, ml/m2 78 (64–110) 71 (60–82) 87 (66–111) 0.050 68 (60–76) 97 (69–120) < 0.001
LVESV, ml/m2 36 (25–69) 26 (21–32) 46 (30–73) 0.001 25 (20–31) 55 (35–85) < 0.001
SV, ml 73 (58–85) 75 (65–89) 72 (55–84) 0.227 76 (65–82) 70 (52–88) 0.291
LVEF, % 52 (35–61) 60 (56–69) 45 (32–58) < 0.001 65 (59–69) 42 (30–53) < 0.001
LGE presence 61 (71) - - - 9 (30) 52 (93) < 0.001
LGE extent, score 5 (0–17) - 9 (4–22) - 0 (0–2) 11 (4–23) < 0.001
LGE extent, % LV volume 7 (0–25) - 13 (6–32) - 0 (0–3) 16 (6–34) < 0.001
SWMA, presence 56 (65) 4 (16) 52 (85) < 0.001 - - -
SWMA extent, score 4 (0–12) 0 (0–0) 5 (3–17) < 0.001 - 7 (4–19) -
  1. Values are median (IQR) or n (%).
  2. Abbreviations: CMR cardiovascular magnetic resonance, IQR interquartile range, LV left ventricular, LVEF left ventricular ejection fraction, LGE late gadolinium enhancement, LVEDD left ventricle end-diastolic diameter, LVEDV left ventricle end-diastolic volume, LVESV left ventricle end-systolic volume, SV stroke volume, SWMA segmental wall motion abnormality.